Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Inventory Average (2018 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Inventory Average for 7 consecutive years, with $32.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 20.19% year-over-year to $32.5 million, compared with a TTM value of $32.5 million through Dec 2025, up 20.19%, and an annual FY2025 reading of $30.3 million, up 29.65% over the prior year.
  • Inventory Average was $32.5 million for Q4 2025 at Agios Pharmaceuticals, up from $31.4 million in the prior quarter.
  • Across five years, Inventory Average topped out at $32.5 million in Q4 2025 and bottomed at $3.3 million in Q2 2022.
  • Average Inventory Average over 4 years is $19.5 million, with a median of $21.1 million recorded in 2024.
  • The sharpest move saw Inventory Average skyrocketed 313.22% in 2023, then grew 20.19% in 2025.
  • Year by year, Inventory Average stood at $6.8 million in 2022, then skyrocketed by 165.95% to $18.2 million in 2023, then soared by 48.68% to $27.0 million in 2024, then rose by 20.19% to $32.5 million in 2025.
  • Business Quant data shows Inventory Average for AGIO at $32.5 million in Q4 2025, $31.4 million in Q3 2025, and $30.2 million in Q2 2025.